Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages The Chemours Company (CC) Shareholders To Inquire About Securities Fraud Class Action

For best results when printing this announcement, please click on link below: Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages The Chemours Company (CC) Shareholders To Inquire About Securities Fraud Class Action Glancy Prongay Wolke & Rotter LLP ( ), a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC ) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”).

Chemours investors have until December 7, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR CHEMOURS COMPANY (CC) INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS What Happened? On August 4, 2026, Chemours announced second quarter 2026 financial results. Among other things, the Company reduced its adjusted EBITDA full-year guidance to $775 million to $825 million (from $800 million to $900 million previously).

59 per share on August 5, 2026, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

Specifically, Defendants failed to disclose to investors that: (i) Defendants had materially overstated aftermarket demand for their Opteon products; (ii) demand for such products was decreasing as a result of Defendants' overselling Opteon products in the preceding fiscal year; (iii) as a result of these undisclosed issues, Defendants' financial guidance for the 2026 fiscal year was unreliable; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.

If you purchased or otherwise acquired The Chemours Company securities during the Class Period, you may move the Court no later than December 7, 2026 to request appointment as lead plaintiff in this putative class action lawsuit. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Charles H.

com) Telephone: 310-201-9150, Toll-Free: 888-773-9224 Visit our website at Follow us for updates on LinkedIn ( ), Twitter ( ), or Facebook If you inquire by email, please include your mailing address, telephone number and number of shares purchased. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. com: Contact Us: Glancy Prongay Wolke & Rotter LLP, 1925 Century Park East, Suite 2100 Los Angeles, CA 90067 Charles H.

com) Telephone: 310-201-9150 Toll-Free: 888-773-9224 Visit our website at